A Dose of Reality with Charles Spence6 Okt 2025

Aleksandra Filipovic, Chief Medical Officer at Gallop Oncology on Perfectionism, Intuition, and the Risk of Building Unsafe Teams

In this episode, I talked with Dr. Aleksandra Filipovic, CMO at Gallop Oncology, a biotech developing first-in-class galectin-9 antibodies for solid tumors and blood cancers. We talked about how perfectionism shaped her early leadership, and what it took to undo it. She shared her take on hiring by “gut feel,” why that can quietly reinforce bias, and what she looks for instead.

Aleksandra also opened up about her childhood—growing up with two cancer-researcher parents, skipping school to attend medical conferences—and how that path eventually led her to leave Serbia with a six-month visa and no real plan. That risk turned into a 20-year career in the UK, and a leadership journey she never could have mapped out.

She once brought a pipette to school for show and tell. These days, she reads nervous systems before resumes, believes leadership is about repair—not perfection—and says her job is to “love a drug into existence.”

Later this year, Aleksandra will be leading a workshop at the Society of Integrative Oncology Annual Meeting in Boston on October 27, 2025, alongside her colleagues Dr. Anna Yusim and Dr. Steve Bierman. The session, “Creating a New Kind of Intelligence in Oncology Practice” will explore neuro-somatic intelligence, noetic medicine, and mental health in oncology and biotech. CME credits and a full training curriculum will be provided. More information below.

Here’s what you’re in for:

Why she’s grateful her career didn’t go according to plan
Why hiring based on “gut feeling” can lead to prejudice if you’re not careful
How perfectionism quietly seeps into leadership

Timestamps:

02:00 Childhood in a Cancer-Obsessed Family

06:30 Why She Left Serbia With No Job and No Plan

09:00 When Your Career Goes “Wrong”, and It’s the Best Thing That Happens

16:45 Interview Advice: “Don’t Perform—Be Honest”

21:30 What Falls Apart When Hiring Goes Wrong

23:30 The Danger of “Gut Feel” in Leadership Hiring

33:00 What It Feels Like When Your Childhood Perfectionism Takes Over at Work

36:00 How She Regulates Herself as a Leader—and Teaches Her Team To Do the Same

39:00 The Workshop: Neurosomatic Tools for Oncology Professionals

About Aleksandra:

Dr. Aleksandra Filipovic is the Chief Medical Officer at Gallop Oncology, where she leads oncology asset sourcing and preclinical to clinical development strategy. With a background as a clinical oncologist and a PhD in Cancer cell biology its safe to say she knows a lot about this area.

Prior to joining Gallop, Aleks still acts as the head of oncology for PureTech health and prior to this she was with BMS and also consulted for Astrazeneca. She is a practicing clinician from Imperial College London, sits on the board of a global oncology educational platform sharing progress in cancer care and hosts a podcast “Into the Body” with Dr. Alex for OncoDaily. She practices applied neuro-somatic-intelligence with cancer patients and applies these same principles in biotech leadership.

Connect with Aleksandra:

Linkedin: https://www.linkedin.com/in/aleksandra-filipovic-md-ph-d-0b63441b/

From Our Guest — Upcoming Workshop for Oncology Professionals

Are you in the oncology field, feeling the weight of burnout and seeking ways to enhance your patient care within the limited time you have in clinic? Reconnect to the core of your work with our upcoming workshop.

Join Dr. Anna Yusim, @SteveBierman from Andrew Weil Center for Integrative Medicine, and myself for an impactful session in Boston on October 27th from 8-9:45AM. This workshop is a part of the Society for Integrative Oncology Annual Meeting.

With only 2 weeks remaining to secure your spot, don't miss this chance to elevate your Oncology Intelligence. Register now using the provided link or QR code: https://lnkd.in/gGupDMa9

Looking forward to your participation!

About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
Website: https://www.discera-search.com/

Opinions and comments expressed by the guest do not represent the company and are fully their own.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(71)

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

In this episode, I talked with Dr. Tobias Kampfenkel, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine. Tobias spent nearly a decade at Janssen building ...

15 Juni 39min

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

In this episode, I talked with Sofia Heigis, Chief Executive Officer of OncoPeptides, about a career path that did not start where she expected. Sofia originally wanted to move into clinical operation...

31 Maj 38min

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

In this episode, I talked with Jens Lindberg, CEO of Medivir AB, a Swedish biotech developing innovative therapies in liver cancer and rare disease. Jens brings over 30 years of late-stage development...

18 Maj 33min

Hubert Truebel, Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

In this episode, I talked with Hubert Truebel, Managing Director at DEBRA Research, to discover a career that wasn’t built traditionally—but through creating opportunities where none formally existed....

4 Maj 28min

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Mars 42min

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

In this episode, I talked with Volker Wacheck, SVP & Head of Clinical Development at Taiho Oncology, where he shared how a PI role in Vienna led him into industry, and why the hardest part wasn’t leav...

9 Mars 29min

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

In this episode, I talked with Dr. Dena Grayson, a physician–scientist with over two decades in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at...

24 Feb 31min

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

In this episode, I talked with Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, a Copenhagen-based biotech developing GIPR antagonists in the obesity space.Richard’s career began in ...

26 Jan 35min